<< back
ReachX logo

ReachX Biotech & Macro Panel - Where are we with Covid-19?

By ReachX Team By ReachX T.

Macro Global Pharmaceuticals Healthcare Biotechnology



Join us on June 4 to discuss Covid-19's scientific perspective and impact on Healthcare Systems and Capital Markets with ReachX Advisors Dr. Graham SchoelfieldAndrew WhelanBenoit Anne and Dr. Sarah Oelsner


Main Topics:


Scientific Perspective:

  • Where do we stand with the current development in fighting the pandemic?
  • Which companies have promising approaches/ clinical trials ?

Healthcare Systems:

  • What lessons can we derive from Covid-19 in terms of impact on the healthcare systems? (UK in particular)
  • How will it affect health policies and healthcare investment?

Impact on Markets:

  • Why the market performed so well over the past few weeks?
  • How would you position yourself in the next few months?


The Panellists:

  • Dr. Graham Schoelfield – Managing Partner at Scitaris, a consulting firm focused on R&D strategy for pharma and biotech firms. PhD in Biochemistry and Molecular Biology.


  • Andrew Whelan – Strategic senior healthcare corporate finance expert and elderly care specialist. Founder and Chairman of Future Care Capital – a charity shaping thinking and practice in health and social care.


  • Benoit Anne – Independent Senior market strategist with a specialization in tactical asset allocation, global macro and emerging markets. Most recently Head of Public Markets Strategy & Analytics with Liberty Mutual Investments in Boston.


  • Dr. Sarah Oelsner – Managing Partner at Scitaris,  a consulting firm focused on R&D strategy for pharma and biotech firms. PhD in Immunology.



04 Jun 2020
from 15:00 to 16:00


The Author

ReachX T.

Due Diligence , Deal Sourcing, Corporate Finance, Consulting, Deal Assessment

Financial Services


Most read